We are live on ! Find out more
PALI icon

Palisade Bio
PALI

26 hedge funds and large institutions have $842K invested in Palisade Bio in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

113% more capital invested

Capital invested by funds: $395K → $842K (+$447K)

44% more funds holding

Funds holding: 18 → 26 (+8)

0.01% more ownership

Funds ownership: 0.01% → 0.02% (+0.01%)

Holders
26
Holders Change
+8
Holders Change %
+44.44%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
Altium Capital Management
New York
+$1.59M
2
Renaissance Technologies
Renaissance Technologies
New York
+$135K
3
SM
Sabby Management
Florida
+$126K
4
SIG
Sargent Investment Group
Maryland
+$121K
5
WAM
Warberg Asset Management
Illinois
+$42.3K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$54.8K
2
SWIG
Strategic Wealth Investment Group
Kentucky
-$22K
3
TRCT
Tower Research Capital (TRC)
New York
-$3.39K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
Altium Capital Management
New York
$559K +$1.59M +7,524 New
SIG
2
Sargent Investment Group
Maryland
$76K +$121K +573 +179%
Renaissance Technologies
3
Renaissance Technologies
New York
$51K +$135K +637 +1,385%
SM
4
Sabby Management
Florida
$44K +$126K +595 New
WAM
5
Warberg Asset Management
Illinois
$15K +$42.3K +200 New
Geode Capital Management
6
Geode Capital Management
Massachusetts
$12K – – –
VF
7
Virtu Financial
New York
$11K +$30.9K +146 New
UBS Group
8
UBS Group
Switzerland
$10K +$22.2K +105 +362%
Vanguard Group
9
Vanguard Group
Pennsylvania
$8K -$54.8K -259 -72%
TSS
10
Two Sigma Securities
New York
$8K +$14.4K +68 +166%
Two Sigma Investments
11
Two Sigma Investments
New York
$8K +$22.7K +107 New
Millennium Management
12
Millennium Management
New York
$7K +$14K +66 +264%
Morgan Stanley
13
Morgan Stanley
New York
$6K +$16.7K +79 +878%
BSW
14
Buckingham Strategic Wealth
Missouri
$5K +$9.74K +46 +307%
PAG
15
Private Advisor Group
New Jersey
$3K – – –
State Street
16
State Street
Massachusetts
$3K – – –
Citadel Advisors
17
Citadel Advisors
Florida
$3K +$8.04K +38 New
TRCT
18
Tower Research Capital (TRC)
New York
$2K -$3.39K -16 -40%
FAT
19
First American Trust
California
$2K – – –
Northern Trust
20
Northern Trust
Illinois
$2K – – –
Wells Fargo
21
Wells Fargo
California
$2K – – –
Fidelity Investments
22
Fidelity Investments
Massachusetts
$2K +$5.72K +27 New
CAN
23
Cetera Advisor Networks
California
$2K +$6.14K +29 New
FPAS
24
Focus Partners Advisor Solutions
Missouri
$1K +$2.75K +13 New
SWIG
25
Strategic Wealth Investment Group
Kentucky
– -$22K -71 Closed

PALI Hedge Fund Activity: Q3 2022 in Review

26 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q3 2022, worth a combined $842K — up 113% from $395K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new PALI positions and 1 closed out — a net gain of 8 holders — while 7 added to existing stakes and 2 trimmed.

The largest buyer was Altium Capital Management, opening a new position worth an estimated $1.59M. The largest seller was Vanguard Group, cutting an estimated $54.8K.

  • 26 institutional investors held Palisade Bio (PALI) as of Q3 2022, up from 18 in Q2 2022.
  • Funds reported $842K of Palisade Bio stock for Q3 2022, up 113% quarter-over-quarter.
  • 9 funds opened new Palisade Bio positions in Q3 2022 and 1 closed out, a net change of +8 holders.
  • The largest Palisade Bio buyer in Q3 2022 was Altium Capital Management, an estimated $1.59M added.
  • The largest Palisade Bio seller in Q3 2022 was Vanguard Group, an estimated $54.8K sold.

Based on aggregated 13F filings for Q3 2022.